AquaBounty Technologies Inc(AQB) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -4.58 | Insider Own | 0.52% | Shs Outstand | 5.2M | Perf Week | 13.97% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 5.1M | Perf Month | -17.21% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 9.4% | Short Float | 3.6% | Perf Quarter | 5.21% |
| Income | -0.02B | P/S | - | EPS this Y | - | Inst Trans | -0.04% | Short Ratio | 0.37 | Perf Half Y | 7.46% |
| Sales | 0.00B | P/B | 1.85 | EPS next 5Y | - | ROA | -8.91% | Short Interest | 0.18M | Perf YTD | 8.6% |
| Book/sh | 0.55 | P/C | 2.75 | EPS past 3/5Y | 8.52% 11.96% | ROE | -20.81% | 52W High | -49.5% ($2.00) | Perf Year | -45.11% |
| Cash/sh | 0.37 | P/FCF | - | Sales past 3/5Y | - | ROIC | -652.65% | 52W Low | 30.46% ($0.77) | Perf 3Y | -78.04% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 75.95% | Gross Margin | - | Volatility(W/M) | 10.6% 9.73% | Perf 5Y | -98.71% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.26 | EPS Q/Q | 63.62% | Profit Margin | - | RSI (14) | 48.6 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.26 | Sales Q/Q | - | SMA20 | 1.37% ($1) | Beta | 1.53 | Target Price | $1 |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -11.44% ($1.14) | Rel Volume | 0.12 | Prev Close | $1.05 |
| Employees | 3 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 1% ($1) | Avg Volume(3M) | 0.49M | Price | $1.01 |
| IPO | 2017/1/9 | Option/Short | No/Yes | Trades | 1869 | Volume | 58,932 | Change | -3.81% |
🐟 AquaBounty Technologies () is a U.S. aquaculture and biotech company that developed "AquAdvantage," the world's first genetically engineered (GE) Atlantic salmon to receive FDA approval. After successively divesting its major farming facilities in Canada and the United States and effectively winding down its GE salmon business, the company has transformed into a micro-cap stock actively exploring new business directions and strategic alternatives.
Over the past 1 year, on the lower side
50% below its 1-year high.
Traded less than usual. That is 12% of its average volume.
AQB has a sound balance sheet but weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -98.7%. The S&P 500 did +79% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 9.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
VXF Vanguard Extended Market Index ETF <0.01% It ranks #19 of 20 in the industry
Based on market cap of $5M.
SDOT#16 Sadot Group Inc $13M PER - 
TULP#17 Bloomia Holdings Inc $13M PER - 
AGRZ#18 Agroz Inc $12M PER - AQB#19 AquaBounty Technologies Inc $5M PER - 
EDBL#20 Edible Garden AG Inc $2M PER - 
FAQ
What kind of company is AQB?
AQB belongs to the Consumer Defensive sector and operates in the Farm Products industry.
What is the market cap of AQB?
The market cap of AQB is approximately $5M, ranking 5,652 within its sector.
What is the 52-week high and low for AQB?
AQB has recorded a 52-week high of $2.00 and a low of $0.77.
